BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/24/2022 8:11:16 AM | Browse: 257 | Download: 371
 |
Received |
|
2021-08-05 14:32 |
|
Peer-Review Started |
|
2021-08-05 14:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-06 21:28 |
|
Revised |
|
2021-11-11 07:28 |
|
Second Decision |
|
2021-12-24 04:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-25 19:31 |
|
Articles in Press |
|
2021-12-25 19:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-12-17 20:07 |
|
Typeset the Manuscript |
|
2022-01-06 10:33 |
|
Publish the Manuscript Online |
|
2022-01-24 08:11 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhen-Dong He, Hai-Yan Yang, Sheng-Sheng Zhou, Man Wang, Qin-Li Mo, Feng-Xiang Huang and Zhi-Gang Peng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zhi-Gang Peng, MD, PhD, Chief Doctor, Professor, Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, 6 Shuang Yong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. pengzhigang@gxmu.edu.cn |
| Key Words |
Chidamide; Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma; Traditional chemotherapy; Case report |
| Core Tip |
The long-term efficacy of traditional chemotherapy in the treatment of primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma is poor, and the main mechanism is the emergence of chemoresistance in lymphoma cells. Chidamide induces apoptosis and growth arrest of lymphoid and hematologic tumor cells and also enhances the sensitivity of lymphoma cells to traditional chemotherapy. This case suggests that chidamide may enhance the efficacy of traditional chemotherapy, and that chidamide combined with traditional chemotherapy may be a promising treatment option for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. |
| Publish Date |
2022-01-24 08:11 |
| Citation |
He ZD, Yang HY, Zhou SS, Wang M, Mo QL, Huang FX, Peng ZG. Chidamide combined with a traditional chemotherapy regimen for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report. World J Clin Cases 2022; 10(4): 1341-1348 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i4/1341.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i4.1341 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
